Lmr Partners LLP Trevena Inc Transaction History

Lmr Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.2 - $0.5 $15,555 - $38,888	77,776 New	77,776 $32,000
Q2 2021 Aug 16, 2021	SELL	$1.46 - $2.25 $144,467 - $222,637	-98,950 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.77 - $2.93 $151,191 - $250,277	85,419 Added 631.28%	98,950 $177,000
Q4 2020 Feb 16, 2021	BUY	$2.13 - $3.26 $28,821 - $44,111	13,531 New	13,531 $29,000
Q3 2018 Nov 14, 2018	SELL	$1.39 - $2.25 $199,654 - $323,181	-143,636 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$1.44 - $2.24 $206,835 - $321,744	143,636 New	143,636 $207,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.